posted on
Apr 01, 2008 08:04AM
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: rare1
Apr 01, 2008 07:26AM
Well I certainly hope your correct. As we both know PTSC has yet to follow any reasonable calculations relative to our industry P/E ratio. Solid numbers from the Q would be a start but, if ES decides to sell hard into a potential rally what do you think the affect will be on retail shareholders? Hard selling into another historical event for this company will, IMO, be devastating to the S/P for the foreseeable future.
Loading...
Loading...
New Message
Please
login
to post a reply